Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Fuji
US Department of Justice
Harvard Business School
Fish and Richardson
Healthtrust
Dow
Mallinckrodt
Merck

Generated: April 24, 2018

DrugPatentWatch Database Preview

Claims for Patent: 5,006,528

« Back to Dashboard

Summary for Patent: 5,006,528
Title: Carbostyril derivatives
Abstract:A novel carbostyril derivative and salt thereof represented by the formula (1) ##STR1## (wherein R is a group of the formula ##STR2## ((wherein R.sup.1 is a C.sub.1- C.sub.3 alkoxy group)), a group of the formula ##STR3## ((wherein R.sup.2 and R .sup.3 are each, at the same time, a chlorine atom, a bromine atom; and R.sup.4 is a hydrogen atom or a chlorine atom)), 2-methyl-3-nitrophenyl group, 3,5-dichlorophenyl group, or a group of the formula ##STR4## ((wherein R.sup.5 is a chlorine atom or a bromine atom; and R.sup.6 is a methyl group)); the carbon-carbon bond between 3- and 4-position in the carbostyril skeleton is a single or double bond).
Inventor(s): Oshiro; Yasuo (Tokushima, JP), Sato; Seiji (Itano, JP), Kurahashi; Nobuyuki (Tokushima, JP)
Assignee: Otsuka Pharmaceutical Co., Ltd. (Tokyo, JP)
Application Number:07/424,719
Patent Claims: 1. A carboxtyril compound or salt thereof of the formula, ##STR34## wherein R is a group of the formula ##STR35## wherein R.sup.1 is a C.sub.1 -C.sub.3 alkoxy group; a group of the formula ##STR36## wherein R.sup.2 and R.sup.3 are at the same time, both chlorine atoms, or both bromine atoms and R.sup.4 is a hydrogen atom or a chlorine atom; a 2-methyl-3-nitrophenyl group; a 3,5-dichlorophenyl group; or a group of the formula ##STR37## wherein R.sup.5 is a chlorine atom or a bromine atom and R.sup.6 is a methyl group; the carbon-carbon bond between the 3- and 4-positions in the carboxtyril skeleton being a single or a double bond.

2. The carboxtyril compound or salt thereof of claim 1, wherein R is a group of the formula ##STR38##

3. The carboxtyril compound or salt thereof of claim 2, wherein R.sup.1 is a methoxy group or an ethoxy group.

4. The carboxtyril compound or salt thereof of claim 1, wherein R is a group of the formula ##STR39##

5. The carbostyril compound or salt thereof of claim 4, wherein R.sup.2 and R.sup.3 are chlorine atoms and R.sup.4 is a hydrogen atom.

6. The carbostyril compound or salt thereof of claim 4, wherein R.sup.2 and R.sup.3 are bromine atoms and R.sup.4 is a hydrogen atom.

7. The carbostyril compound or salt thereof of claim 4, wherein R.sup.2, R.sup.3 and R.sup.4 are chlorine atoms.

8. The carbostyril compound or salt thereof of claim 1, wherein R is a 2-methyl-3-nitrophenyl group or a 3,5-dichlorophenyl group.

9. The carbostyril compound or salt thereof of claim 1, wherein R is a group of the formula ##STR40##

10. The carbostyril compound or salt thereof of claim 9, wherein R.sup.5 is a chlorine atom.

11. The carbostyril compound or salt thereof of claim 9, wherein R.sup.5 is a bromine atom.

12. 7-{4-[4-(2,3 -Dichlorophenyl)-1-piperazinyl]butoxy}-3,4-dihydrocarbostyril.

13. 7-{4-[4-(b 2,3-Dichlorophenyl)-1-piperazinyl]-butoxy}carbostyril.

14. 7-{4-[4-(2-Ethoxyphenyl)-1-piperazinyl]butoxy}-3,4-dihydrocarbostyril.

15. 7-{4-[4-]2-Ethoxyphenyl)-1-piperazinyl]butoxy}-carbostyril.

16. A pharmaceutical composition for treating schizophrenia containing, as the active ingredient, a carbostyril compound or pharmaceutically acceptable salt thereof of claim 1 and a pharmaceutically acceptable carrier.

17. The pharmaceutical composition of claim 16, wherein the carbostyril compound or salt thereof is 7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy}-3,4-dihydrocarbostyril.

18. The pharmaceutical composition of claim 16, wherein the carbostyril compound or salt thereof is 7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy}carbostyril.

19. The pharmaceutical composition of claim 16, wherein the carbostyril compound or salt thereof is 7-{4-[4-(2-ethoxyphenyl)-1-piperazinyl]butoxy}-3,4-dihydrocarbostyril.

20. The pharmaceutical composition of claim 16, wherein the carbostyril compound or salt thereof is 7-{4-[4-(2-ethoxyphenyl)-1-piperazinyl]butoxy}carbostyril.

21. The pharmaceutical composition for treating schizophrenia containing, as the active ingredient, a carbostyril compound or pharmaceutically acceptable salt thereof of claim 3 and a pharmaceutically acceptable carrier.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Chinese Patent Office
Federal Trade Commission
Mallinckrodt
Merck
McKinsey
Chubb
Citi
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.